Cargando…

Acute Pancreatitis in Association With Type 2 Diabetes and Antidiabetic Drugs: A population-based cohort study

OBJECTIVE: Previous observational studies have found an increased risk of acute pancreatitis among type 2 diabetic patients. However, limited information is available on this association and specifically on the role of antidiabetic treatment. Our aim, therefore, was to further assess the risk of acu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez-Perez, Antonio, Schlienger, Raymond G., Rodríguez, Luis A. García
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992194/ https://www.ncbi.nlm.nih.gov/pubmed/20833867 http://dx.doi.org/10.2337/dc10-0842

Ejemplares similares

Pancreatic safety of vildagliptin in patients with type 2 diabetes mellitus: A European, noninterventional, postauthorization safety study
por: Williams, Rachael, et al.
Publicado: (2019)

Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?
por: Ruiz-Tamayo, Irene, et al.
Publicado: (2016)

Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002–2013: Nationwide population-based cohort study
por: Ko, Seung-Hyun, et al.
Publicado: (2016)

The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth
por: Feng, Yin-Hsun, et al.
Publicado: (2011)

Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK
por: González-Pérez, Antonio, et al.
Publicado: (2021)

The association between circulatory, local pancreatic PCSK9 and type 2 diabetes mellitus: The effects of antidiabetic drugs on PCSK9
por: Lu, Fengyuan, et al.
Publicado: (2023)

Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections
por: Sun, Bao, et al.
Publicado: (2021)

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management
por: Chaudhury, Arun, et al.
Publicado: (2017)

New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer
por: Lu, Yunxia, et al.
Publicado: (2015)

The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea
por: Lee, Da Young, et al.
Publicado: (2018)

Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study
por: Faillie, Jean-Luc, et al.
Publicado: (2014)

Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications
por: Huri, Hasniza Zaman, et al.
Publicado: (2015)

Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus
por: Liu, Wenhui, et al.
Publicado: (2022)

Optimizing weight control in diabetes: antidiabetic drug selection
por: Kalra, S, et al.
Publicado: (2010)

Reply to ‘Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer''
por: Lu, Yunxia, et al.
Publicado: (2016)

Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UK
por: Gonzalez Perez, Antonio, et al.
Publicado: (2023)

Pathways Targeted by Antidiabetes Drugs Are Enriched for Multiple Genes Associated With Type 2 Diabetes Risk
por: Segrè, Ayellet V., et al.
Publicado: (2015)

Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development
por: Singh, Desh Deepak, et al.
Publicado: (2022)

Adherence to Oral Antidiabetic Drugs in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis
por: Piragine, Eugenia, et al.
Publicado: (2023)

Antidiabetic Drug Prescription Pattern in Hospitalized Older Patients with Diabetes
por: Ardoino, Ilaria, et al.
Publicado: (2023)

Treating Diet-Induced Diabetes and Obesity with Human Embryonic Stem Cell-Derived Pancreatic Progenitor Cells and Antidiabetic Drugs
por: Bruin, Jennifer E., et al.
Publicado: (2015)

Pharmacogenetics of Oral Antidiabetic Drugs
por: Becker, Matthijs L., et al.
Publicado: (2013)

Nephroprotective Properties of Antidiabetic Drugs
por: Gerdes, Christian, et al.
Publicado: (2023)

A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs
por: Funch, D, et al.
Publicado: (2014)

Use of the Japanese health insurance claims database to assess the risk of acute pancreatitis in patients with diabetes: comparison of DPP-4 inhibitors with other oral antidiabetic drugs
por: Yabe, D, et al.
Publicado: (2015)

Clinical inertia in patients with type 2 diabetes treated with oral antidiabetic drugs: Results from a Japanese cohort study (JDDM53)
por: Maegawa, Hiroshi, et al.
Publicado: (2020)

Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs
por: Signorovitch, J E, et al.
Publicado: (2013)

Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications
por: Huri, Hasniza Zaman, et al.
Publicado: (2015)

Comparative Efficacy of Novel Antidiabetic Drugs on Albuminuria Outcomes in Type 2 Diabetes: A Systematic Review
por: Liu, Geng, et al.
Publicado: (2023)

Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
por: Patorno, Elisabetta, et al.
Publicado: (2018)

Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population
por: García Rodríguez, Luis A, et al.
Publicado: (2005)

Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
por: Olatunde, Ahmed, et al.
Publicado: (2021)

Initiating second-line antidiabetic medication among older adults with type 2 diabetes on Metformin
por: DeCarlo, Kristen, et al.
Publicado: (2022)

Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38)
por: Kanatsuka, Azuma, et al.
Publicado: (2015)

Efficacy and safety of luseogliflozin added to various oral antidiabetic drugs in Japanese patients with type 2 diabetes mellitus
por: Seino, Yutaka, et al.
Publicado: (2015)

Remission of hyperglycemia after withdrawal of oral antidiabetic drugs in Japanese patients with early‐stage type 2 diabetes
por: Hirukawa, Hidenori, et al.
Publicado: (2018)

Glycaemic impact of treatment intensification in patients with type 2 diabetes uncontrolled with oral antidiabetes drugs or basal insulin
por: Buysman, Erin K., et al.
Publicado: (2018)

Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70)
por: Shirabe, Shinichiro, et al.
Publicado: (2022)

Cost-Effectiveness of Newer Antidiabetic Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review
por: Zhu, Jiejin, et al.
Publicado: (2023)

Impact of Contextual-Level Social Determinants of Health on Newer Antidiabetic Drug Adoption in Patients with Type 2 Diabetes
por: Li, Yujia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_so91f7poe1cmu0lj868jvmcfqn